Annuaire
Vous pouvez découvrir dans cet annuaire les startups et scaleups de l'IA Générative détectées par Motherbase. Elles sont classées par ordre alphabétique.
- Vous pouvez les sélectionner en fonction de leur domaine technologique dans le menu ci-dessus.
- Dans le moteur de recherche ci-dessous, vous pouvez faire une recherche des mots clefs présents dans les propositions de valeur des solutions. (Attention ! Celles-ci sont en anglais).
- tous les "tags" sont des fiches sont "cliquables". Vous pouvez donc "naviguer" en sélectionnant les tags par technologie ou par secteur, ...
Et toutes les remarques et suggestions sont les bienvenues.
- Vous pouvez les sélectionner en fonction de leur domaine technologique dans le menu ci-dessus.
- Dans le moteur de recherche ci-dessous, vous pouvez faire une recherche des mots clefs présents dans les propositions de valeur des solutions. (Attention ! Celles-ci sont en anglais).
- tous les "tags" sont des fiches sont "cliquables". Vous pouvez donc "naviguer" en sélectionnant les tags par technologie ou par secteur, ...
Et toutes les remarques et suggestions sont les bienvenues.
Absci
Creating Drugs at the Speed of Ai Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug CreationTM platform unlocks the potential to accelerate time to clinic and increase the probability of success by … [voir plus]
conversationHEALTH
As of January 8, 2024, conversationHEALTH has joined forces with Swoop (www.swoop.com), revolutionizing patient and provider engagement throughout the healthcare industry. This strategic partnership combines conversationHEALTH's expertise in developing advanced conversational AI solutions with Swoop's proficiency in creating precise DTC and HCP audiences. Together, we aim to deliver an unparalleled … [voir plus]
Evozyne
Evozyne designs novel protein therapeutics to solve previously unaddressable patient needs. [voir plus]
iktos
Artificial intelligence for new drug design We are Iktos. A start-up company specializing in the development of proprietary artificial intelligence technologies and software for ligand-based and structure-based de novo drug design focusing on multi parametric optimization. Our de novo design algorithm is based on deep generative models with reinforcement learning. … [voir plus]
Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #GANs, #GANs-RL, #DL #aging, #longevity Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning … [voir plus]
MDClone
Unlock healthcare data. Transform care. See #syntheticdata in action. See an ADAMS Platform demo today: Link in bio MDClone offers an innovative, self-service data analytics environment powering exploration, discovery, and collaboration throughout healthcare ecosystems, cross-institutionally, and globally. The powerful underlying infrastructure of the MDClone ADAMS Platform allows users to overcome … [voir plus]
Paige
Bridging Vision & Precision Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a … [voir plus]
Redesign Science
Biology Simulated Founded in 2017, Redesign Science is a platform biotech working at the interface of physics-based molecular simulation and deep learning to create generative AI for drug discovery. We deploy our platform technology to develop first-in-class Protein Interaction Modulators against validated targets known to drive progression of multiple oncogenic … [voir plus]
Valence Labs
Industrializing scientific discovery to radically improve lives. Valence Labs, powered by Recursion, is industrializing scientific discovery to radically improve lives. Our vision is that highly autonomous systems capable of Nobel-worthy insights will usher in a new wave of scientific discovery. Following the acquisition of Valence Discovery by Recursion (NASDAQ: RXRX) … [voir plus]